InMed Pharmaceuticals Inc. Suite 310 – 815 W. Hastings Street Vancouver, British Columbia V6C 1B4InMed Pharmaceuticals Inc. • June 28th, 2024 • Pharmaceutical preparations
Reference is made to the At The Market Offering Agreement, dated as of April 7, 2022 (the “ATM Agreement”), between InMed Pharmaceuticals Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”). This letter (the “Amendment”) constitutes an agreement between the Company and Wainwright to amend the ATM Agreement as set forth herein. Defined terms that are used but not defined herein shall have the meanings ascribed to such terms in the ATM Agreement.
